Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Brief Somalia.
Press releases published on September 3, 2025
Carbon Capture Made Scalable: Decarbontek Debuts Breakthrough Modular Adsorbent Technology
BOSTON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Massachusetts-based climate tech startup Decarbontek today announced a major breakthrough in carbon capture technology with the launch of its proprietary modular structured adsorbent platform, designed to …
MATTER Launches Major Initiative to Improve Health System in Ukraine
Minneapolis, MN, Sept. 03, 2025 (GLOBE NEWSWIRE) -- MATTER today announced a major initiative to strengthen the health system in Ukraine. This effort, involving a very challenging place in the world, implements diverse strategies by leveraging MATTER's …
BVI Unveils Virtuoso® – A Novel Dual-Function Surgical Platform for Cataract and Vitreoretinal Procedures
BVI announces Virtuoso®, its first dual-function phaco-vitrectomy system designed to deliver advanced control, efficiency, and versatility for both cataract and vitreoretinal surgery. European debut planned for 2025 Global ophthalmic congresses in Europe ( …
10 Surgeons Join USOSM Partner Practices in Eight States
IRVING, Texas, Sept. 03, 2025 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management (USOSM) is pleased to announce 10 additional oral and maxillofacial surgeons have joined partner practices in eight states – Texas, Washington, Kansas, Oregon, Massachusetts, …
Ernexa Therapeutics Announces Presentation At The H.C. Wainwright 27th Annual Global Investment Conference
CAMBRIDGE, Mass., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the treatment of advanced cancer and autoimmune disease, today announced it will be featured as a presenting …
PharmAla Incorporates Australian Entity for Clinical Research
TORONTO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including its …
Dogwood Therapeutics to Participate in Fireside Chat at the H.C. Wainwright 27th Annual Global Investment Conference
ATLANTA, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), a development-stage biotechnology company developing new medicines to treat pain and fatigue-related disorders, today announces it will participate in …
Adagene Appoints Immuno-Oncology Pioneer, Axel Hoos, M.D., Ph.D., as Executive Advisor
SAN DIEGO and SUZHOU, China, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the discovery and development of antibody-based therapies, today announced the appointment of Dr. Axel Hoos as Executive Advisor …
PacBio and EpiCypher Partner to Deliver Novel Insights into Epigenomics with Fiber-seq Workflow
MENLO PARK, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced that EpiCypher, a recognized leader in epigenetics tools, has joined the PacBio …
ControlUp Doubles Down on Commitment to Healthcare with Strategic Initiatives and CHIME Membership
SAN FRANCISCO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- ControlUp, a global leader in Digital Employee Experience (DEX) management tools, today announced it has expanded its strategic focus within the healthcare sector, deepening its commitment to improving …
Persephoni Launches Strategic Sponsorship with American Cancer Society’s BrightEdge to Accelerate Oncology Innovation
RESEARCH TRIANGLE PARK, N.C., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Persephoni BioSciences LLC ("Persephoni"), a leading global life sciences venture studio, is proud to announce a $1.5 million sponsorship to American Cancer Society BrightEdge LLC (" …
EndoQuest Advances Multicenter PARADIGM Trial with Completion of Procedure at AdventHealth Orlando
Houston, TX, Sept. 03, 2025 (GLOBE NEWSWIRE) -- EndoQuest Robotics, Inc., a pioneering leader in endoluminal robotic surgical technology, today announced that AdventHealth Orlando has successfully completed its first procedure in the PARADIGM Trial ( …
Northwest Kidney Centers and Outset Medical Announce Collaboration to Grow Home Hemodialysis
SAN JOSE, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Northwest Kidney Centers, the first organization to establish a home hemodialysis program, today announced a collaboration with Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company …
GRI Bio to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Live webcast presentation with CEO, Dr. Marc Hertz, on September 9th at 3:00 PM ET LA JOLLA, CA, Sept. 03, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of …
Limited Healthcare Access Leaves Families Paying the Price
CHICAGO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- As economic pressures reshape how Americans access healthcare, a new survey by WellNow Urgent Care reveals a concerning trend: families are increasingly forced to delay or skip medical treatment due to cost and …
Migraine and Back-to-School: Experts Share Tips to Reduce Triggers and Support Students
Providence, RI, Sept. 03, 2025 (GLOBE NEWSWIRE) -- As the school year begins, the Association of Migraine Disorders (AMD) is highlighting the challenges students with migraine face during the back-to-school transition. Returning to the classroom means …
Artelo Biosciences Announces Positive Interim Phase 2 CAReS Results for the Treatment of Cancer Anorexia-Cachexia Syndrome (CACS)
Catalyst for Advancing Discussions with Pharmaceutical Companies that have Expressed Interest in ART27.13 for CACS Consistent Improvements in Weight Gain, Lean Body Mass, and Activity were Observed Across Treated Patients including +6.4% Mean Weight Gain …
Outlook Therapeutics to Present at the 2025 EURETINA Innovation Spotlight (EIS)
ISELIN, N.J., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on optimizing the standard of care for bevacizumab for the treatment of retina diseases, today announced that it will present at …
Journey Medical Corporation to Participate in September 2025 Investor Conferences
SCOTTSDALE, Ariz., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company primarily focused on selling and marketing U.S. Food and Drug Administration (“ …
PolyPid to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment Conference
PETACH TIKVA, Israel, Sept. 03, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced that senior management will participate in the upcoming …